Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-7b9c58cd5d-hxdxx Total loading time: 0 Render date: 2025-03-14T18:56:46.970Z Has data issue: false hasContentIssue false

11 - Cost effectiveness of screening for disease

Published online by Cambridge University Press:  05 June 2012

Rebecca Richards-Kortum
Rebecca Richards-Kortum
Affiliation:
Rice University, Houston
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Biomedical Engineering for Global Health , pp. 305 - 319
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Littenberg, B. Technology assessment in medicine. Academic Medicine. 1992 Jul; 67(7): 424–8.CrossRefGoogle Scholar
Drummond, MF. Methods for the Economic Evaluation of Health Care Programmes. 2nd edn. Oxford: Oxford University Press; 1997.Google Scholar
Cantor, SB, Ganiats, TG. Incremental cost-effectiveness analysis: the optimal strategy depends on the strategy set. Journal of Clinical Epidemiology. 1999 Jun; 52(6): 517–22.CrossRefGoogle ScholarPubMed
Bergus, GR, Cantor, SB, Ebell, MH, Ganiats, TG, Glasziou, PP, Hagen, MD, et al. A glossary of medical decision-making terms. Primary Care. 1995 Jun; 22(2): 385–93.Google ScholarPubMed
Cantor, SB. Pharmacoeconomics of coxib therapy. Journal of Pain and Symptom Management. 2002 Jul; 24(1 Suppl.): S28–37.CrossRefGoogle ScholarPubMed
Goldie, S. A public health approach to cervical cancer control: considerations of screening and vaccination strategies. International Journal of Gynaecology and Obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2006 Nov; 94 Suppl. 1: S95–105.CrossRefGoogle ScholarPubMed
Mandelblatt, JS, Fahs, MC. The cost-effectiveness of cervical cancer screening for low-income elderly women. Jama. 1988 Apr 22–29; 259(16): 2409–13.CrossRefGoogle ScholarPubMed
Power, EJ. From the Congressional Office of Technology Assessment. Jama. 1990 Jun 13; 263(22): 2996.CrossRefGoogle ScholarPubMed
Fahs, MC, Mandelblatt, J, Schechter, C, Muller, C. Cost effectiveness of cervical cancer screening for the elderly. Annals of Internal Medicine. 1992 Sep 15; 117(6): 520–7.CrossRefGoogle ScholarPubMed
Hagen, MD, Garber, AM, Goldie, SJ, Lafata, JE, Mandelblatt, J, Meltzer, D, et al. Does cost-effectiveness analysis make a difference? Lessons from Pap smears. Symposium. Medical Decision Making. 2001 Jul–Aug; 21(4): 307–23.CrossRefGoogle ScholarPubMed
Goldie, SJ, Kim, JJ, Wright, TC. Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstetrics and Gynecology. 2004 Apr; 103(4): 619–31.CrossRefGoogle ScholarPubMed
Goldie, SJ, Gaffikin, L, Goldhaber-Fiebert, JD, Gordillo-Tobar, A, Levin, C, Mahe, C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. The New England Journal of Medicine. 2005 Nov 17; 353(20): 2158–68.CrossRefGoogle ScholarPubMed
Goldie, SJ, Kuhn, L, Denny, L, Pollack, A, Wright, TC. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. Jama. 2001 Jun 27; 285(24): 3107–15.CrossRefGoogle ScholarPubMed
Goldie, SJ. Health economics and cervical cancer prevention: a global perspective. Virus Research. 2002 Nov; 89(2): 301–9.CrossRefGoogle ScholarPubMed
Salinsky, E. “Clinical Preventive Services: When is the Juice Worth the Squeeze?” National Health Policy Forum Issue Brief. 2005; 806.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×